Osimatab 80mg Tablet

Introduction to Osimatab 80mg Tablet 

Osimatab 80mg Tablet is manufactured by Eskayef Pharmaceuticals Ltd. Osimatab 80mg contains Osimertinib, a third-generation EGFR tyrosine kinase inhibitor used in the treatment of non-small cell lung cancer (NSCLC).

Osimatab 80mg works by blocking the abnormal EGFR signals that promote cancer cell growth, helping to slow or stop the spread of cancer. It is used both as a first-line treatment for metastatic NSCLC and for patients whose cancer has progressed despite previous treatments. Always follow the patient's healthcare provider’s guidance when taking Osimatab for the best outcomes.